Jiangsu, China

Bigao Pan

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Jiangsu Hansoh Medicine Institute Co., Ltd., Jiangsu Hansoh Pharmaceutical Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Co., Ltd.. Active years: 2016.



 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bigao Pan: Innovator in Pharmaceutical Chemistry

Introduction

Bigao Pan is a notable inventor in the field of pharmaceutical chemistry, particularly recognized for his work on organic amine salts of azilsartan. His contributions have significant implications for the development of antihypertensive medications.

Latest Patents

Bigao Pan holds a patent titled "Organic Amine Salts Of Azilsartan, Preparation Method And Use Thereof." This patent discloses organic amine salts of azilsartan, detailing their preparation method and therapeutic applications. The pharmaceutical composition derived from this compound is designed to be used in the manufacture of effective antihypertensive medicaments.

Career Highlights

Throughout his career, Bigao Pan has been associated with prominent companies in the pharmaceutical industry, including Jiangsu Hansoh Pharmaceutical Co., Ltd. and Jiangsu Hansoh Pharmaceutical Group Co., Ltd. His work in these organizations has contributed to advancements in drug formulation and development.

Collaborations

Bigao Pan has collaborated with notable professionals in his field, including Longbin Huang and Baohai Yang. These collaborations have fostered innovation and enhanced research efforts in pharmaceutical chemistry.

Conclusion

Bigao Pan's contributions to the field of pharmaceutical chemistry, particularly through his patent on azilsartan, highlight his role as an innovator in developing effective antihypertensive treatments. His work continues to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…